Grifols (GRFS) Other financing activities (2011 - 2020)

Grifols (GRFS) posted Other financing activities of $5.3 million for Q1 2020, down 52.75% quarter-over-quarter from $11.2 million in Q4 2019, and down 54.36% year-on-year from $11.6 million in Q2 2019.

Grifols (GRFS) Other financing activities (2011 - 2020) Analysis & Trends

Grifols (GRFS) has reported Other financing activities for 9 consecutive years, with $5.3 million the latest figure, recorded in Q1 2020.

  • Other financing activities for Q1 2020 came in at $5.3 million, down 54.36% year-over-year; the trailing twelve-month figure through Mar 2020 was $27.4 million (up 185.1% YoY), and the FY2025 annual result was $43.1 million, down 22.49% from the prior year.
  • Other financing activities was $5.3 million for Q1 2020 at Grifols, down from $11.2 million in the prior quarter.
  • Over five years, Other financing activities peaked at $182.0 million in Q4 2017 and troughed at -$103.6 million in Q1 2017.
  • Average Other financing activities over 5 years is $15.7 million, with a median of $5.3 million recorded in 2020.
  • Year-over-year, Other financing activities plunged 1745.48% in 2016 and surged 2902.98% in 2017.
  • Over 5 years, Other financing activities stood at $6.1 million in 2016, then surged by 2902.98% to $182.0 million in 2017, then plunged by 100.39% to -$700817.4 in 2018, then surged by 1701.54% to $11.2 million in 2019, then tumbled by 52.75% to $5.3 million in 2020.
  • Per Business Quant data, the three most recent Other financing activities figures were $5.3 million in Q1 2020, $11.2 million in Q4 2019, and $11.6 million in Q1 2019.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,066.16 Bn 1,060.88 Bn 16.22 Bn
2 Johnson & Johnson 611.69 Bn 589.64 Bn 15.96 Bn
3 AbbVie 444.34 Bn 434.99 Bn 10.78 Bn
4 Astrazeneca 284.94 Bn 277.05 Bn 12.61 Bn
5 Merck 224.23 Bn 218.58 Bn 12.09 Bn
6 Amgen 195.12 Bn 183.08 Bn 5.87 Bn
7 Gilead Sciences 156.45 Bn 148.73 Bn 5.52 Bn
8 Pfizer 136.01 Bn 123.24 Bn -1.21 Bn
9 Novartis Ag 113.45 Bn 113.67 Bn -
10 Grifols - - -

Historic Data

Download Data
DateValue
Mar 31, 2020 5.30 Mn
Mar 31, 2020 5.30 Mn
Dec 31, 2019 11.22 Mn
Dec 31, 2019 11.22 Mn
Mar 31, 2019 11.62 Mn
Mar 31, 2019 11.62 Mn
Dec 31, 2018 -700,817.41
Dec 31, 2018 -700,817.41
Jun 30, 2018 -2.48 Mn
Jun 30, 2018 -2.48 Mn
Mar 31, 2018 1.18 Mn
Mar 31, 2018 1.18 Mn
Dec 31, 2017 181.96 Mn
Dec 31, 2017 181.96 Mn
Jun 30, 2017 116.86 Mn
Jun 30, 2017 116.86 Mn
Mar 31, 2017 -103.56 Mn
Mar 31, 2017 -103.56 Mn
Dec 31, 2016 6.06 Mn
Dec 31, 2016 6.06 Mn